These reports should include key details such as who was involved, when and where the incident occurred, type of error, contributing factors, and corrective actions taken
Heart palpitations are not listed as a common adverse effect in the FDA-approved prescribing information for tirzepatide, and there is no established direct causal link between tirzepatide use and palpitations in the pivotal clinical trial data
Who was studied in HEART-2: These were not healthy volunteers
Semaglutide is formulated specifically for once-weekly injection
The mean patient age was 66 years (range 60 to 74)
In February, researchers from the University of Leicester and the Leicester Diabetes Centre published a review article on obesity in the "International Journal of Obesity," introducing the current and future drug development pipeline for the treatment of obesity, with special attention given to novel therapies based on the mechanisms of gut incretin hormones